Correlation Between Halozyme Therapeutics and Replimune
Can any of the company-specific risk be diversified away by investing in both Halozyme Therapeutics and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Halozyme Therapeutics and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Halozyme Therapeutics and Replimune Group, you can compare the effects of market volatilities on Halozyme Therapeutics and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Halozyme Therapeutics with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Halozyme Therapeutics and Replimune.
Diversification Opportunities for Halozyme Therapeutics and Replimune
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Halozyme and Replimune is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Halozyme Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Halozyme Therapeutics are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Halozyme Therapeutics i.e., Halozyme Therapeutics and Replimune go up and down completely randomly.
Pair Corralation between Halozyme Therapeutics and Replimune
Given the investment horizon of 90 days Halozyme Therapeutics is expected to generate 2.9 times less return on investment than Replimune. But when comparing it to its historical volatility, Halozyme Therapeutics is 4.44 times less risky than Replimune. It trades about 0.34 of its potential returns per unit of risk. Replimune Group is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 1,153 in Replimune Group on November 9, 2024 and sell it today you would earn a total of 253.00 from holding Replimune Group or generate 21.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Halozyme Therapeutics vs. Replimune Group
Performance |
| Timeline |
| Halozyme Therapeutics |
| Replimune Group |
Halozyme Therapeutics and Replimune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Halozyme Therapeutics and Replimune
The main advantage of trading using opposite Halozyme Therapeutics and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Halozyme Therapeutics position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |